External Funding Opportunities

Funding Opportunity

Deadline

NIH Stephen I. Katz Early Stage Investigator Research Project Grant (R01)

January 26, 2021

NIH Utilizing In Vitro Functional Genomics Advances for Gene-Environment (G x E) Discovery and Validation (R01) 

February 1, 2021

NIH Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01)

February 5, 2021

NIH NOSI: Academy of Finland (AKA) – National Institutes of Health (NIH) Partnership Program

February 5, 2021

NIH Clinical Translation of Activated Optical Fluorescence Methods and Technologies for Sensitive Cancer Detection in Vivo (R01)

February 10

NIH Assay Validation of High Quality Markers for Clinical Studies in Cancer  The purpose of this FOA is to accelerate the adoption and validation of molecular/cellular/imaging markers and assays for cancer detection, diagnosis, prognosis, monitoring, and prediction of response or resistance to treatment, as well as markers for cancer prevention and control. This FOA will also support the validation of pharmacodynamic markers and markers of toxicity.

 February 18

NIH Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21)

February 22

NIH Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21)

February 22

NIH Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33) 

February 22

NIH Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01)

February 22

NIH Notice of Special Interest: Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues

March 5

NIH Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01) 

March 15

NIH Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18)  This FOA invites applications from investigators who strive to expand their research trajectories through the acquisition of new knowledge and skills in the areas of basic psychological processes, sociological processes, and/or biomedical pathways—expertise that is beyond and enhances their current areas of expertise. The program will support career development experiences and a small-scale research project that will provide experienced investigators with the scientific competencies required to conduct independent research projects that more thoroughly investigate interrelationships among behavioral, biological, endocrine, epigenetic, immune, inflammatory, neurological, psychological, and/or social processes. This program requires basic experimental studies with humans.

March 17, 2021

NIH Multidisciplinary Studies of HIV/AIDS and Aging  This FOA encourages applications at the intersection of HIV and aging by addressing two overarching objectives: 1) to improve understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment; and 2) to improve approaches for testing, prevention, and treatment of HIV infection, and management of HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying our current understanding of aging science.

  • R01 Deadline: May 7
  • R21 Deadline: May 7

 May 7

NIH-NCI Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21)

June 8

NIH-NCI Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01)

June 8

NIH-NCI Sustained Support for Informatics Technologies for Cancer Research and Management (U24)

June 8

NIH-NCI Advanced Development of Informatics Technologies for Cancer Research and Management (U24)

June 8

NIH Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards  The overarching goal of this pilot program is to enhance the retention of investigators facing critical life events who are transitioning to the first renewal of their first independent research project grant award or to a second new NIH research project grant award. Retention at the first renewal or continuous NIH research project grant support is crucial for sustaining both the ongoing research NIH has made an investment in and for retaining diversity in the biomedical research workforce. Deadline:  Varies by awarding IC

 Varies

NIH Notice of Special Interest (NOSI): Use of Biological "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers  The purpose of this Notice of Special Interest (NOSI) is to continue advancing our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS), particularly the non-AIDS defining malignancies which are now a leading cause of death in HIV-infected individuals. Research efforts that identify specific contributions of HIV infection and its potential interaction with other pathogens towards the development and pathogenesis of these cancers and provide information on the clinical outcomes of such cancers in the HIV-infected population are sought.  Deadline:  Applies to due dates on or after May 7, 2020 through January 8, 2023

 Varies

NIH Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications  The purpose of this NOSI is to encouraging new applications to advance research activities relevant to synthetic biology.  The overarching goal(s) of this Notice are to: 1) develop tools and technologies to control and reprogram biological systems; 2) apply synthetic biology approaches for the development of biomedical technologies; 3) increase the fundamental understanding of synthetic biology concepts as they relate to human health; and 4) gain fundamental biological knowledge through the application of synthetic biology approaches. Deadline: Varies by IC

 Varies

NIH Research Supplements to Promote Diversity in Health-Related Research  The NIH and the CDC hereby notify PD(s)/PI(s) holding specific types of research grants  that funds are available for administrative supplements to enhance the diversity of the research workforce by recruiting and supporting students, postdoctorates, and eligible investigators from diverse backgrounds, including those from groups that have been shown to be underrepresented in health-related research. This supplement opportunity is also available to PD(s)/PI(s) of research grants who are or become disabled and need additional support to accommodate their disability in order to continue to work on the research project.  Administrative supplements must support work within the scope of the original project. Deadline: Varies by awarding IC

 Varies

Funding Opportunity

Deadline

The Mark Foundation for Cancer Research – Endeavor Award  The Mark Foundation Endeavor Awards support collaborative research projects that bring together investigators with diverse areas of expertise to tackle challenges in the prevention, diagnosis, and treatment of cancer. These grants are awarded to teams of three or more investigators to generate and integrate data from diverse lines of research and transform those insights into advances for cancer patients that could not be achieved by individual efforts.

March 1 – LOI; July – Applications (by invite)

DoD-CDMRP Breast Cancer Research Program  The BCRP challenges the scientific community to design research that will address the urgency of ending breast cancer. Specifically, the BCRP seeks to accelerate high-impact research with clinical relevance, encourage innovation and stimulate creativity, and facilitate productive collaborations. The following FY21 opportunities have been announced:

  • Breakthrough Award Levels 1 and 2  Letter of Intent due March 11; Application due March 25
  • Breakthrough Award Level 3  Preproposal due March 12; Invited application due June 23
  • Breakthrough Award Level 4  Preproposal due March 12; Invited application due June 23
  • Era of Hope Scholar Award  Letter of Intent due March 11; Application due March 25
  • Innovator Award  Preproposal due March 12; Application due June 23
  • Transformative Breast Cancer Consortium Award  Preproposal due March 12; Invited application due June 23
Varies

NSF Biophotonics

On-going

NSF Division of Molecular and Cellular Biosciences: Investigator-initiated research projects (MCB)  

On-going

DOE-JGI CSP New Investigator 

On-going

NSF Big Ideas updates

Varies

DOD-CDMRP Peer Reviewed Cancer Research Program (PRCRP)  The PRCRP is charged by Congress with the mission to investigate cancer risks and knowledge gaps that may be relevant to active duty Service members, their families, other military beneficiaries, and the American public.  Mechanisms include:  Virtual Cancer Center Director Award; Career Development Award – Fellow Option; Career Development Award – Virtual Cancer Center Scholar Option; Idea Award; Impact Award; Behavioral Health Science Award; and Translational Team Science Award. 

Varies

DOD-CDMRP Lung Cancer Research Program (LCRP)

The vision of the FY20 LCRP is to eradicate deaths and suffering from lung cancer to better the health and welfare of military Service members, Veterans, and the American public. As such, the LCRP will support and integrate research from multiple disciplines for risk assessment, prevention, early detection, diagnosis, and treatment for the control and cure of lung cancer. Mechanisms include:  Concept award, Idea development award, and Investigator initiated translational research award. Deadlines:  vary by mechanism

Varies

Damon Runyon Cancer Research Foundation  The Damon Runyon Cancer Research Foundation, we fund high-risk, high-reward cancer research.  The foundation provides a variety of cancer-related funding opportunities. Deadline:  Varies by opportunity

Varies